Business Context and Reporting Period
This Form 8-K Current Report was filed by Catheter Precision, Inc. (NYSE American: VTAK) on December 28, 2023. The report details significant changes to the Company's Board of Directors and executive management team effective January 2, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on corporate governance and personnel changes.
Material Changes
- Board Appointment: John P. Francis was appointed as a Class III Director to fill the vacancy left by the resignation of Susanne Meline on December 28, 2023. Mr. Francis is Mr. Meline's spouse.
- CEO Appointment: David Jenkins was named Chief Executive Officer, continuing his role as Executive Chairman of the Board. He had previously served as interim CEO since April 28, 2023.
- CFO and Secretary Appointment: Margrit Thomassen was named interim Chief Financial Officer and Secretary, replacing Steve Passey, whose employment was terminated effective December 31, 2023.
- Related Party Transactions: Mr. Francis holds beneficial ownership of Company securities acquired in the January 2023 merger, including 14.056 shares of Series X Convertible Preferred Stock (valued at approximately $90,098.96 at merger closing) and 2,575 shares of Common Stock.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of market risks. It notes that Ms. Thomassen's prior employment included roles at SeaCap Management LLC, an affiliate of CEO David Jenkins, and that she has served as Controller since the 2023 merger.
Investor Verification Checklist
- Verify the specific terms of the Series X Convertible Preferred Stock held by John P. Francis and the conditions for the remaining contingent conversion.
- Review the Company's Form 10-K for the year ended December 31, 2022, for detailed biographical information and related party transaction disclosures regarding David Jenkins.
- Confirm the transition timeline for the interim CFO role and the status of the terminated CFO, Steve Passey.
- Monitor future filings for the formal election of directors at the 2024 annual meeting.